Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2026)
Vanda Pharmaceuticals (VNDA) reported Exchange Rate Effect of -$57000.0 for Q1 2026, down 216.33% on a YoY basis from $49000.0 in Q1 2025, and down 385.0% sequentially from $20000.0 in Q4 2025.
Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 10 years of Exchange Rate Effect data on file, last reported at -$57000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 216.33% year-over-year to -$57000.0; the trailing twelve-month figure through Mar 2026 stood at -$83000.0 (up 17.0% YoY), and the FY2025 full-year result was $23000.0, up 114.11% from the prior year.
- Exchange Rate Effect eased to -$57000.0 in Q1 2026, from $20000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $183000.0 in Q4 2022 to a low of -$202000.0 in Q4 2024.
- A 5-year average of $6764.7 and a median of $20000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 993.33% in 2025, while the deepest fall reached 364.71% in 2025.
- Tracing VNDA's Exchange Rate Effect over 5 years: stood at $183000.0 in 2022, then slipped by 18.03% to $150000.0 in 2023, then sank by 234.67% to -$202000.0 in 2024, then soared by 109.9% to $20000.0 in 2025, then plunged by 385.0% to -$57000.0 in 2026.
- Business Quant data shows VNDA's Exchange Rate Effect at -$57000.0 in Q1 2026, $20000.0 in Q4 2025, and -$180000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57,000.00 |
| Mar 31, 2026 | -57,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | -180,000.00 |
| Sep 30, 2025 | -180,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | -202,000.00 |
| Dec 31, 2024 | -202,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Dec 31, 2023 | 150,000.00 |